IDiyas

For the Inventor, By the Inventor

Vienna, Austria

Nabriva Therapeutics Ag


USPTO Granted Patents = 18



Forward Citations = 130

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Werner Heilmayer (9 out of 15 patents)

silverMedal Rosemarie Mang (5 out of 6 patents)

bronzeMedal Heinz Berner (5 out of 9 patents)

4.  Klaus Thirring (4 out of 6 patents)

5.  Rosemarie Riedl (4 out of 5 patents)

6.  Atchyuta Rama Chandra Murty Bulusu (4 out of 4 patents)

7.  Gerd Ascher (4 out of 29 patents)

8.  Dirk B Strickmann (3 out of 3 patents)

9.  Johannes Hildebrandt (3 out of 7 patents)

10.  Lee Spence (2 out of 3 patents)

11.  Ingolf Macher (2 out of 2 patents)

12.  Andreas Berger (2 out of 6 patents)

13.  Rudolf Badegruber (2 out of 2 patents)

14.  Rodger Novak (2 out of 4 patents)

15.  Mathias Ferencic (2 out of 3 patents)


18 patents:

1. 9701628 - 12-epi pleuromutilins (2017-07-11),
2. 9278920 - Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes (2016-03-08),
3. 9120808 - Substituted clavulanic acid (2015-09-01),
4. 9120727 - Process for the preparation of pleuromutilins (2015-09-01),
5. 9061980 - Organic compounds (2015-06-23),
6. 8987498 - Enantiomerically pure amines (2015-03-24),
7. 8624033 - Pleuromutilins and process for the preparation of pleuromutilins (2014-01-07),
8. 8343972 - Organic compounds (2013-01-01),
9. 8334389 - Process for the preparation of pleuromutilins (2012-12-18),
10. 8222447 - Organic compounds (2012-07-17),
11. 8173685 - Pleuromutilin derivatives and their use as antimicrobials (2012-05-08),
12. 8153689 - Pleuromutilin derivatives for the treatment of diseases mediated by microbes (2012-04-10),
13. 8088823 - Tuberculosis treatment using pleuromutilin derivatives (2012-01-03),
14. 8071643 - Pleuromutilin derivatives for the treatment of diseases mediated by microbes (2011-12-06),
15. 7790749 - [object Object] (2010-09-07),
Nabriva Therapeutics AG is a clinical stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections caused by multidrug-resistant bacteria. With a focus on developing innovative therapies to combat the global threat of antibiotic resistance, Nabriva Therapeutics aims to provide differentiated treatment options for patients in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#48 in Vienna

#196 in Austria

#33,147 in the World

...
Vienna, Austria

Nabriva Therapeutics Ag

Forward Citations = 130

36 inventors:

goldMedal Werner Heilmayer (9 out of 15 patents)

silverMedal Rosemarie Mang (5 out of 6 patents)

bronzeMedal Heinz Berner (5 out of 9 patents)

4.  Klaus Thirring (4 out of 6 patents)

5.  Rosemarie Riedl (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…